AMORPHOUS MELANOCORTIN-4 RECEPTOR AGONIST

Abstract: the present invention relates to an amorphous compound represented by formula 1, a method for preparing the same, and a pharmaceutical composition comprising the same. the amorphous compound represented by formula 1 of the present invention may be characterized by xrd patterns, dsc profiles, and/or tga profiles.

Inventor(s): Jin Ok HAM, Ho Yeon LEE, Ji Yoon KIM, Sung Won KIM, Seul Ah CHUN, Sang Dae LEE, Jong Won PARK

CPC Classification: C07D207/16 (HETEROCYCLIC COMPOUNDS (macromolecular compounds ))

Search for rejections for patent application number 20250179016